Zinc as a potential coadjuvant in therapy for type 2 diabetes. (Q38130502)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23964394 AND SRC:MED&resulttype=core&format=json

7 March 2020

title

Zinc as a potential coadjuvant in therapy for type 2 diabetes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23964394 AND SRC:MED&resulttype=core&format=json

7 March 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23964394 AND SRC:MED&resulttype=core&format=json

7 March 2020

Alvaro Pérez

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23964394 AND SRC:MED&resulttype=core&format=json

7 March 2020

1

Manuel Ruz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23964394 AND SRC:MED&resulttype=core&format=json

7 March 2020

4

Juana Codoceo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23964394 AND SRC:MED&resulttype=core&format=json

7 March 2020

9

Jose Galgani

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23964394 AND SRC:MED&resulttype=core&format=json

7 March 2020

Francisco Pérez-Bravo

13

object named as

Francisco Perez-Bravo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23964394 AND SRC:MED&resulttype=core&format=json

7 March 2020

author name string

Fernando Carrasco

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23964394 AND SRC:MED&resulttype=core&format=json

7 March 2020

Jorge Inostroza

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23964394 AND SRC:MED&resulttype=core&format=json

7 March 2020

Karen Basfi-fer

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23964394 AND SRC:MED&resulttype=core&format=json

7 March 2020

Alejandra Valencia

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23964394 AND SRC:MED&resulttype=core&format=json

7 March 2020

Karla Vásquez

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23964394 AND SRC:MED&resulttype=core&format=json

7 March 2020

Gloria López

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23964394 AND SRC:MED&resulttype=core&format=json

7 March 2020

Miguel Arredondo

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23964394 AND SRC:MED&resulttype=core&format=json

7 March 2020

publication date

1 June 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23964394 AND SRC:MED&resulttype=core&format=json

Food and Nutrition Bulletin

7 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23964394 AND SRC:MED&resulttype=core&format=json

7 March 2020

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23964394 AND SRC:MED&resulttype=core&format=json

7 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23964394 AND SRC:MED&resulttype=core&format=json

7 March 2020

page(s)

215-221

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23964394 AND SRC:MED&resulttype=core&format=json

Diagnosis and classification of diabetes mellitus

7 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1177/156482651303400210

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/156482651303400210

A two-step model for development of non-insulin-dependent diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/156482651303400210

The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/156482651303400210

Oral antihyperglycemic therapy for type 2 diabetes: scientific review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/156482651303400210

Insulin secretion in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/156482651303400210

Release of Incompletely Processed Proinsulin Is the Cause of the Disproportionate Proinsulinemia of NIDDM

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/156482651303400210

Defects in insulin secretion and action in the pathogenesis of type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/156482651303400210

Beta cell apoptosis in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/156482651303400210

The beta-cell in human type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/156482651303400210

Genetic and biochemical pathways of beta-cell failure in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/156482651303400210

Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/156482651303400210

Metabolic flexibility in response to glucose is not impaired in people with type 2 diabetes after controlling for glucose disposal rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/156482651303400210

Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/156482651303400210

Oxidative stress and antioxidant treatment in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/156482651303400210

Nutritional supplementation for type 2 diabetes: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/156482651303400210

The oxidative stress status in diabetes mellitus and diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/156482651303400210

Beta-cell dysfunction in subjects with impaired glucose tolerance and early type 2 diabetes: comparison of surrogate markers with first-phase insulin secretion from an intravenous glucose tolerance test

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/156482651303400210

Global and societal implications of the diabetes epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/156482651303400210

Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/156482651303400210

Standards of Medical Care in Diabetes—2011

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/156482651303400210

Beta-cell deterioration determines the onset and rate of progression of secondary dietary failure in type 2 diabetes mellitus: the 10-year follow-up of the Belfast Diet Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/156482651303400210

Effects of rosiglitazone, glyburide, and metformin on β-cell function and insulin sensitivity in ADOPT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/156482651303400210

Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/156482651303400210

Trace elements in glucometabolic disorders: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/156482651303400210

Effect of chromium supplementation on glucose metabolism and lipids: a systematic review of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/156482651303400210

Antioxidants in the Treatment of Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/156482651303400210

Micronutrients and diabetic retinopathy a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/156482651303400210

Zinc in specialized secretory tissues: roles in the pancreas, prostate, and mammary gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/156482651303400210

Zinc coordination, function, and structure of zinc enzymes and other proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/156482651303400210

Zinc mediation of the binding of human growth hormone to the human prolactin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/156482651303400210

Zinc and redox signaling: perturbations associated with cardiovascular disease and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/156482651303400210

Zinc supplementation and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/156482651303400210

THE INSULIN AND THE ZINC CONTENT OF NORMAL AND DIABETIC PANCREAS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/156482651303400210

Serum mineral changes in alloxan diabetes before and after treatment with some hypoglycemic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/156482651303400210

Video image analysis of labile zinc in viable pancreatic islet cells using a specific fluorescent probe for zinc

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/156482651303400210

Role of zinc in insulin biosynthesis. Some possible zinc-insulin interactions in the pancreatic B-cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/156482651303400210

Zinc might protect oxidative changes in the retina and pancreas at the early stage of diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/156482651303400210

Zinc and diabetes--clinical links and molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/156482651303400210

Identification and cloning of a beta-cell-specific zinc transporter, ZnT-8, localized into insulin secretory granules

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/156482651303400210

Diabetes-linked zinc transporter ZnT8 is a homodimeric protein expressed by distinct rodent endocrine cell types in the pancreas and other glands

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/156482651303400210

Intracellular zinc homeostasis in leukocyte subsets is regulated by different expression of zinc exporters ZnT-1 to ZnT-9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/156482651303400210

The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/156482651303400210

Zinc, a regulator of islet function and glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/156482651303400210

In vivo expression and functional characterization of the zinc transporter ZnT8 in glucose-induced insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/156482651303400210

Beta cell-specific Znt8 deletion in mice causes marked defects in insulin processing, crystallisation and secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/156482651303400210

Genome-wide association studies provide new insights into type 2 diabetes aetiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/156482651303400210

A genome-wide association study identifies novel risk loci for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/156482651303400210

Zinc transporter gene expression is regulated by pro-inflammatory cytokines: a potential role for zinc transporters in beta-cell apoptosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/156482651303400210

Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/156482651303400210

Overexpression of metallothionein in pancreatic beta-cells reduces streptozotocin-induced DNA damage and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/156482651303400210

Transgenic copper/zinc superoxide dismutase modulates susceptibility to type I diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/156482651303400210

Novel -209A/G MT2A polymorphism in old patients with type 2 diabetes and atherosclerosis: relationship with inflammation (IL-6) and zinc.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/156482651303400210

Effect of zinc supplementation on serum leptin levels and insulin resistance of obese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/156482651303400210

Zinc and glycemic control: a meta-analysis of randomised placebo controlled supplementation trials in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/156482651303400210

Effects of zinc supplementation on diabetes mellitus: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/156482651303400210

Prospective study of zinc intake and risk of type 2 diabetes in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/156482651303400210

Intake of antioxidants and risk of type 2 diabetes in a cohort of male smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/156482651303400210

Hyperzincuria in insulin treated diabetes mellitus—its relation to glucose homeostasis and insulin administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/156482651303400210